Based on forecast data, the UK's import of penicillins or streptomycins in dosage forms is expected to decrease from $104.68 million in 2024 to $94.245 million in 2028. This indicates a steady year-on-year decline. For reference, the import value stood at $107 million in 2023. The year-on-year percentage variations show a consistent decline with a negative trajectory indicating shrinking demand or possibly enhanced local production. The five-year Compound Annual Growth Rate (CAGR) reflects this negative trend, suggesting persistent contraction in imports over the analyzed period.

Future trends to watch for include:

The impact of Brexit on pharmaceutical trade policies and tariffs that might affect import volumes.
Shifts toward local production capabilities or alternative suppliers due to changes in UK healthcare policies.
Developments in the global pharmaceutical market that could affect pricing dynamics and import demand.